Variant position: 212 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: 461 The length of the canonical sequence.
Location on the sequence:
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human AIKSEYPEPYASPPQ-PGLPY GYPEPFSGGPNVPELILQLLQ
Mouse TIKSEYPEPYASPPQQPGPPY SYPEPFSGGPNVPELILQLL
Rat TIKSEYPEPYASPPQQPGPPY SYPEPFSGGPNVPELILQLL
Pig AIKSEYPEPYASPPQ-PGPPY GYPEPFSGGPGVPELIVQLL
Bovine AIKSEYPEPYASPPQ-PGPPY GYPEPFSGGPGVPELILQLL
Horse AIKSEYPEPYASPPQ-PGPPY GYPEPFSGGPGVPELILQLL
Baker's yeast ----------------PGNP- --------------------
Sequence annotation in neighborhood: The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
Type: the type of sequence feature. Positions: endpoints of the sequence feature. Description: contains additional information about the feature.
Type Positions Description
1 – 461 Steroidogenic factor 1
203 – 203 Phosphoserine; by CDK7
194 – 194 Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO)
194 – 194 K -> R. Loss of sumoylation.
Human male infertility associated with mutations in NR5A1 encoding steroidogenic factor 1.
Bashamboo A.; Ferraz-de-Souza B.; Lourenco D.; Lin L.; Sebire N.J.; Montjean D.; Bignon-Topalovic J.; Mandelbaum J.; Siffroi J.P.; Christin-Maitre S.; Radhakrishna U.; Rouba H.; Ravel C.; Seeler J.; Achermann J.C.; McElreavey K.;
Am. J. Hum. Genet. 87:505-512(2010)
Cited for: VARIANTS SPGF8 ALA-123; LEU-129; LEU-131; CYS-191; SER-212 AND ASN-238; CHARACTERIZATION OF VARIANTS SPGF8 LEU-131; CYS-191; SER-212 AND ASN-238;
Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.